Pages that link to "Q43273894"

The following pages link to Immunomodulator agent-related lymphoproliferative disorders (Q43273894):

Displaying 27 items.

• Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types (Q33823265) (← links)
• Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus. (Q34121629) (← links)
• EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management (Q35040644) (← links)
• NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus. (Q37503717) (← links)
• The role of dendritic cells in CNS autoimmunity (Q37706120) (← links)
• New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009. (Q37716646) (← links)
• Classical Hodgkin's lymphoma arising in different host's conditions: Pathobiology parameters, therapeutic options, and outcome (Q37832198) (← links)
• Primary Central Nervous System Immunomodulatory Therapy-Induced Lymphoproliferative Disorder in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature (Q38546691) (← links)
• EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. (Q39232131) (← links)
• Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. (Q40055511) (← links)
• B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. (Q40250056) (← links)
• Epstein–Barr virus‐related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma (Q40319047) (← links)
• Predictable biomarkers of developing lymphoma in patients with Sjögren syndrome: a nationwide population-based cohort study. (Q41472929) (← links)
• Reactive tonsillar enlargement showing strong 18F-FDG uptake during the follow-up of follicular lymphoma. (Q42259648) (← links)
• Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia. (Q42264992) (← links)
• Spontaneous remission of chemo-immunotherapy related, non-transplant Epstein-Barr virus-associated lymphoproliferative disorder in a patient with chronic lymphocytic leukemia (Q42739833) (← links)
• Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. (Q46016553) (← links)
• Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study. (Q51000616) (← links)
• Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases (Q59360900) (← links)
• Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma (Q59802034) (← links)
• Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report (Q64087449) (← links)
• Cutaneous Hodgkin-type lymphoproliferative lesion associated with immunomodulatory therapy for ulcerative colitis (Q83284424) (← links)
• Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a via PI3K p110α Activation (Q89620766) (← links)
• A case study of t(14;22)(q32;q11) involving immunoglobulin heavy and light chain in follicular lymphoma (Q92645025) (← links)
• Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting (Q93139609) (← links)
• Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders (Q93139625) (← links)
• Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A   NK cell effector function (Q102141569) (← links)